These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 18788899)
1. Aluminum modulates effects of beta amyloid(1-42) on neuronal calcium homeostasis and mitochondria functioning and is altered in a triple transgenic mouse model of Alzheimer's disease. Drago D; Cavaliere A; Mascetra N; Ciavardelli D; di Ilio C; Zatta P; Sensi SL Rejuvenation Res; 2008 Oct; 11(5):861-71. PubMed ID: 18788899 [TBL] [Abstract][Full Text] [Related]
2. Aluminum exposure through the diet: metal levels in AbetaPP transgenic mice, a model for Alzheimer's disease. Gómez M; Esparza JL; Cabré M; García T; Domingo JL Toxicology; 2008 Jul; 249(2-3):214-9. PubMed ID: 18571827 [TBL] [Abstract][Full Text] [Related]
3. Role of phenylalanine 20 in Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity. Boyd-Kimball D; Mohmmad Abdul H; Reed T; Sultana R; Butterfield DA Chem Res Toxicol; 2004 Dec; 17(12):1743-9. PubMed ID: 15606152 [TBL] [Abstract][Full Text] [Related]
4. An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity. Ferreiro E; Resende R; Costa R; Oliveira CR; Pereira CM Neurobiol Dis; 2006 Sep; 23(3):669-78. PubMed ID: 16844381 [TBL] [Abstract][Full Text] [Related]
5. Enhanced caffeine-induced Ca2+ release in the 3xTg-AD mouse model of Alzheimer's disease. Smith IF; Hitt B; Green KN; Oddo S; LaFerla FM J Neurochem; 2005 Sep; 94(6):1711-8. PubMed ID: 16156741 [TBL] [Abstract][Full Text] [Related]
7. Potential pathogenic role of beta-amyloid(1-42)-aluminum complex in Alzheimer's disease. Drago D; Bettella M; Bolognin S; Cendron L; Scancar J; Milacic R; Ricchelli F; Casini A; Messori L; Tognon G; Zatta P Int J Biochem Cell Biol; 2008; 40(4):731-46. PubMed ID: 18060826 [TBL] [Abstract][Full Text] [Related]
8. Altered oxidant-mediated intraneuronal zinc mobilization in a triple transgenic mouse model of Alzheimer's disease. Sensi SL; Rapposelli IG; Frazzini V; Mascetra N Exp Gerontol; 2008 May; 43(5):488-92. PubMed ID: 18068923 [TBL] [Abstract][Full Text] [Related]
9. Calcium dyshomeostasis and neurotoxicity of Alzheimer's beta-amyloid protein. Kawahara M; Negishi-Kato M; Sadakane Y Expert Rev Neurother; 2009 May; 9(5):681-93. PubMed ID: 19402778 [TBL] [Abstract][Full Text] [Related]
10. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease. Busche MA; Eichhoff G; Adelsberger H; Abramowski D; Wiederhold KH; Haass C; Staufenbiel M; Konnerth A; Garaschuk O Science; 2008 Sep; 321(5896):1686-9. PubMed ID: 18802001 [TBL] [Abstract][Full Text] [Related]
11. Why is the amyloid beta peptide of Alzheimer's disease neurotoxic? Rauk A Dalton Trans; 2008 Mar; (10):1273-82. PubMed ID: 18305836 [TBL] [Abstract][Full Text] [Related]
12. Insights into amyloid-beta-induced mitochondrial dysfunction in Alzheimer disease. Wang X; Su B; Perry G; Smith MA; Zhu X Free Radic Biol Med; 2007 Dec; 43(12):1569-73. PubMed ID: 18037122 [TBL] [Abstract][Full Text] [Related]
13. Overactivation of calcineurin induced by amyloid-beta and prion proteins. Agostinho P; Lopes JP; Velez Z; Oliveira CR Neurochem Int; 2008 May; 52(6):1226-33. PubMed ID: 18295934 [TBL] [Abstract][Full Text] [Related]
14. Transient intraneuronal A beta rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice. Christensen DZ; Kraus SL; Flohr A; Cotel MC; Wirths O; Bayer TA Acta Neuropathol; 2008 Dec; 116(6):647-55. PubMed ID: 18974993 [TBL] [Abstract][Full Text] [Related]
15. Molecular modeling of zinc and copper binding with Alzheimer's amyloid beta-peptide. Han D; Wang H; Yang P Biometals; 2008 Apr; 21(2):189-96. PubMed ID: 17629774 [TBL] [Abstract][Full Text] [Related]
16. Study of neurotoxic intracellular calcium signalling triggered by amyloids. Villalobos C; Caballero E; Sanz-Blasco S; Núñez L Methods Mol Biol; 2012; 849():289-302. PubMed ID: 22528098 [TBL] [Abstract][Full Text] [Related]
17. Cell cycle-driven neuronal apoptosis specifically linked to amyloid peptide Abeta1-42 exposure is not exacerbated in a mouse model of presenilin-1 familial Alzheimer's disease. Malik B; Currais A; Soriano S J Neurochem; 2008 Jul; 106(2):912-6. PubMed ID: 18466334 [TBL] [Abstract][Full Text] [Related]
18. Calcium dysregulation in Alzheimer's disease: recent advances gained from genetically modified animals. Smith IF; Green KN; LaFerla FM Cell Calcium; 2005; 38(3-4):427-37. PubMed ID: 16125228 [TBL] [Abstract][Full Text] [Related]
19. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation. Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756 [TBL] [Abstract][Full Text] [Related]
20. beta-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. Butterfield DA; Hensley K; Harris M; Mattson M; Carney J Biochem Biophys Res Commun; 1994 Apr; 200(2):710-5. PubMed ID: 8179604 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]